Loading...

SCL: Future Performance Will Reflect Stable Metrics And Index Inclusion

Published
09 Feb 25
Updated
10 Apr 26
Views
151
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
44.8%
7D
1.4%

Author's Valuation

NZ$6.913.3% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 10 Apr 26

SCL: Stable Sector Framework Will Support Future Upside Case

Analysts have kept their NZ$6.90 price target on Scales unchanged, pointing to largely stable assumptions around fair value, discount rate, growth and margins, while recent sector research helps support the case for maintaining the current valuation framework.

Analyst Commentary

Recent sector research around chemicals and related industrial names gives some context for how analysts are thinking about valuation frameworks and risk, even when direct references to Scales are limited. Here is how the current sentiment broadly breaks down.

Bullish Takeaways

  • Bullish analysts are comfortable holding firm on valuation inputs such as discount rate and margins. This signals a view that current assumptions already reflect known sector risks.
  • Sector work on chemicals points to ongoing investor interest in companies with clear earnings visibility. Analysts see this as supportive of maintaining Scales' existing valuation framework rather than tightening it.
  • The unchanged NZ$6.90 fair value suggests analysts see limited reason, based on current information, to raise execution risk or haircut growth assumptions in their models.
  • Consistency between recent sector research and the Scales valuation approach helps reinforce the idea that the shares are being assessed using a framework aligned with broader market practice.

Bearish Takeaways

  • Bearish analysts point to the unchanged target as a sign that any potential upside from improved execution or growth is not being priced in aggressively at this stage.
  • Sector research around chemicals also highlights that earnings can be sensitive to input costs and demand swings. This keeps a lid on how far valuation multiples are stretched for Scales in current models.
  • The decision to leave the discount rate and margin assumptions steady indicates that analysts still see enough uncertainty in the sector to avoid easing their risk or profitability settings.
  • With the valuation framework largely unchanged, bearish analysts view the current target as leaving limited room for error if delivery against existing forecasts becomes challenging.

Valuation Changes

  • Fair Value: NZ$6.90 remains unchanged, indicating the same headline valuation level as before.
  • Discount Rate: 7.27% is steady, with no change in the rate used to discount future cash flows.
  • Revenue Growth: 15.65% (NZ$ terms) is effectively unchanged, with only an immaterial rounding difference.
  • Net Profit Margin: 5.72% remains consistent, reflecting no shift in expected profitability assumptions.
  • Future P/E: 16.27x is maintained, showing no adjustment to the multiple applied to projected earnings.
0 viewsusers have viewed this narrative update

Key Takeaways

  • Expanding premium apple focus and growing protein and logistics segments strengthen revenue growth, margin expansion, and earnings resilience.
  • Enhanced sustainability and traceability initiatives improve access to premium markets and mitigate regulatory risks.
  • High dependence on New Zealand horticulture and apples, alongside rising competition, regulatory challenges, and cost pressures, threatens margins and long-term growth prospects.

Catalysts

About Scales
    Engages in manufacturing and trading of food ingredients in New Zealand, Asia, Europe, North America, and internationally.
What are the underlying business or industry changes driving this perspective?
  • Strong and growing demand for premium apples in Asia and the Middle East, combined with Scales' ongoing strategic shift toward a higher proportion of premium apple varieties (now ~75% of volumes vs. 72% last year), is likely to further enhance revenue per unit and drive future top-line growth.
  • Successful commissioning and scaling up of new protein processing plants in Melbourne, North America, and the Netherlands, with further projects under consideration, pave the way for organic and inorganic expansion in the Global Proteins division, supporting sustained EBITDA and earnings growth from FY26 onward.
  • Diversification efforts through growth in Proteins and Logistics segments dilute earnings volatility from horticulture, reduce revenue cyclicality, and increase the resilience of overall earnings, which should gradually improve net margins and stability of cash flows.
  • Scales' established infrastructure and global footprint, especially the integration of logistics capabilities with growing export volumes, creates operational efficiencies and bargaining power, likely reducing unit costs and supporting margin expansion over the long term.
  • Enhanced focus on sustainability initiatives and food traceability (e.g., decarbonization targets and materiality assessments) improves access to premium export markets and can command higher pricing, supporting both revenue growth and lower regulatory risk.

Scales Earnings and Revenue Growth

Scales Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Scales's revenue will grow by 15.6% annually over the next 3 years.
  • Analysts assume that profit margins will shrink from 11.2% today to 5.7% in 3 years time.
  • Analysts expect earnings to reach NZ$79.6 million (and earnings per share of NZ$0.45) by about April 2029, down from NZ$101.0 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting NZ$95.1 million in earnings, and the most bearish expecting NZ$65.3 million.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 16.3x on those 2029 earnings, up from 8.6x today. This future PE is greater than the current PE for the NZ Food industry at 9.5x.
  • Analysts expect the number of shares outstanding to grow by 1.72% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.27%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Significant exposure to apple and horticulture markets in New Zealand creates geographic and product concentration risk; adverse weather, biosecurity threats, or climate volatility could materially reduce crop yields and impact core revenues and earnings.
  • Increasing international competition-particularly from lower-cost horticultural producers in South America, South Africa, and Eastern Europe-may exert downward pressure on pricing and erode export market share, negatively affecting revenue growth and profitability.
  • Ongoing and increasing regulatory risk, including higher tariffs (e.g., petfood tariffs on the U.S. market rising from 10% to 15%), uncertain trade agreements, and growing environmental compliance demands, could increase operating costs and exert pressure on net margins and export earnings.
  • Rising costs in labor and inputs (driven by persistent labor shortages and wage inflation in New Zealand horticulture, as well as supply chain disruptions and tightening global freight markets) threaten to outpace productivity improvements, compressing net margins and potentially hindering earnings growth.
  • Softer or more volatile demand trends in key segments (e.g., slower growth in global petfood market and possible shifts in consumer preference away from traditional apple varieties) may undermine forward revenue assumptions and limit long-term earnings growth if sectoral tailwinds do not materialize as projected.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of NZ$6.9 for Scales based on their expectations of its future earnings growth, profit margins and other risk factors.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be NZ$1.4 billion, earnings will come to NZ$79.6 million, and it would be trading on a PE ratio of 16.3x, assuming you use a discount rate of 7.3%.
  • Given the current share price of NZ$5.98, the analyst price target of NZ$6.9 is 13.3% higher. Despite analysts expecting the underlying business to decline, they seem to believe it's more valuable than what the market thinks.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Scales?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives